Support and Resistance Levels
Past performance
About Ipca Laboratories Ltd Ipca Laboratories Limited is a leading Indian pharmaceutical company, incorporated in 1949. It is renowned for manufacturing and marketing over 350 formulations and 80 APIs across various therapeutic segments, with products sold in over 100 countries. The company operates 18 manufacturing units in India and is recognized for its production of APIs such as Atenolol, Chloroquine Phosphate, and Furosemide. Ipca's facilities are approved by top regulatory bodies, including the US FDA and UK MHRA.
Ipca has a history of strategic expansions through acquisitions and joint ventures, notably acquiring Krebs Biochemicals & Industries Ltd., Pisgah Labs Inc., and significant stakes in Lyka Labs Ltd. The company emphasizes R&D, aiming to develop new drug delivery systems and formulations for global markets. Recent expansions include acquiring further stakes in Trophic Wellness Private Ltd. and Lyka Labs Ltd. as well as merging subsidiaries Ramdev Chemical Pvt. Ltd. and Tonira Exports Ltd. with the company, enhancing its operational capacity and market reach.